معرفی
Lan Zhao, PhD, is an Assistant Professor in the Department of Orthopedic Surgery at Rush Medical College, Rush University. Her research focuses on understanding molecular mechanisms underlying joint degeneration and developing innovative therapies for osteoarthritis (OA) using CRISPR gene-editing technologies, microRNA regulation, and stem cell biology. Key areas of investigation include inflammatory pathways, bone remodeling, and the role of epigenetic regulators in joint homeostasis.
Education details are not explicitly stated in the provided text, but her extensive publication history indicates advanced training in molecular biology and orthopedic research. Research interests prominently feature osteoarthritis pathogenesis, with emphasis on β-catenin signaling, miRNA networks (miR-204/211), and growth factor interactions. She has pioneered models for studying temporomandibular joint (TMJ) OA and disc degeneration through genetically engineered mouse studies.
Her recent work (2020–2024) demonstrates exploration of CRISPR-mediated gene activation/inhibition for therapeutic purposes, investigating how targeting Sox9, RelA, and β-catenin can enhance cell-based therapies. She also examines systemic factors like metformin’s AMPK pathway effects on OA progression. Notable contributions include establishing novel immunocompetent cancer pain models and developing high-throughput viral detection strategies for pandemic response.
No scientific awards are listed in the provided data. Her research spans translational medicine, molecular diagnostics (miRNA biomarkers), and cross-disciplinary approaches integrating immunology, genetics, and engineering. Collaborations likely involve orthopedic surgeons, geneticists, and bioengineers given the technical nature of her published work.
